Table 2.
Percentage of Monocyte Subset and CD86 Positive Monocytes and Serum Levels of Procalcitonin and IL-17 in the Studied Groups
| Control Group | Patients Group | Test Value | P-value | ||
|---|---|---|---|---|---|
| N=30 | N=30 | ||||
| Monocytes (%) | Median (IQR) | 6.4 (3.6–9.7) | 7.1 (3.3–9.6) | −0.133 | 0.894 |
| Range | 0.1–19.7 | 1.4–22.3 | |||
| CD86+ monocytes (%) | Median (IQR) | 24 (14.9–30.7) | 78.35 (44.1–91.4) | −6.003 | 0.000 |
| Range | 5.1–45.5 | 26.5–100 | |||
| CD86 MFI | Median (IQR) | 2.4 (1.3–5.2) | 1.65 (1.3–3.9) | −0.407 | 0.684 |
| Range | 1–7.5 | 1.1–7.2 | |||
| Classical monocytes (%) | Median (IQR) | 80.6 (75.8–86.8) | 81.2 (46.6–88.3) | −0.673 | 0.501 |
| Range | 9–93.7 | 1.1–95.1 | |||
| Intermediate monocytes (%) | Median (IQR) | 4.5 (3–7.7) | 10 (6–33.5) | −3.645 | 0.000 |
| Range | 0.4–27.8 | 2.9–49.3 | |||
| Nonclassical monocytes | Median (IQR) | 0.25 (0–1) | 4.3 (1.9–11) | −5.348 | 0.000 |
| Range | 0–10.4 | 0.8–48.8 | |||
| CD16 MFI | Median (IQR) | 3.4 (2.5–5.7) | 8.7 (5.2–15) | −4.318 | 0.000 |
| Range | 1–24.7 | 2.7–45 | |||
| Procalcitonin (pg/mL) | Median (IQR) | 156 (143–166) | 225.5 (190–303) | −5.924 | 0.000 |
| Range | 0.2–201 | 143–738 | |||
| IL-17 (ng/L) | Median (IQR) | 101.5 (84–134) | 421.5 (162–646) | −5.501 | 0.000 |
| Range | 65–354 | 101–728 | |||
Abbreviations: MFI, mean fluorescence intensity; IL-17, interleukin 17; SD, standard deviation; IQR, interquartile range.